EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PLGA/SF/linagliptin wound matrix-induced membrane promotes diabetic wounds healing by inhibiting macrophage pyroptosis

Yizhuo Ren iD, Yanlong Wang, Kaixuan Cai, Xianzheng Lin, Tao Tang, Meng Yin

Regenerative Biomaterials · 22.01.2026 · 13

DOI: 10.1093/rb/rbag048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 08.05.2026. Verfasst von Yizhuo Ren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Children’s Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic wounds often exhibit delayed healing because of persistent inflammation, thus, remaining in the inflammatory phase. A key factor driving the delayed healing is pyroptosis, a proinflammatory form of programmed cell death which leads to the excessive release of inflammatory mediators. And macrophages are deeply involved in the entire process of wound inflammation. In this study, to regulate the pathological inflammation, we developed linagliptin-loaded hybrid PLGA [Poly(lactic-co-glycolic acid)]/SF(Silk Fibroin) membranes by electrostatic spinning. This advanced biomaterial with suitable physicochemical properties and biocompatibility is designed to provide a sustained release of linagliptin. Our in vitro experiments demonstrated that linagliptin effectively suppresses the macrophage pyroptosis through the noncanonical pathway, thereby reducing the secretion of key pro-inflammatory factors and improving the function of cells involved in wound healing. Furthermore, our in vivo experiments demonstrated that the PLGA/SF/linagliptin membrane promotes the healing of diabetic wounds and shortens the inflammatory phase of wounds, while improving skin regeneration. The collective results confirm the linagliptin’s capacity to inhibit nonclassical pyroptosis and the PLGA/SF/linagliptin wound matrix-induced membrane’s potential to promote wound healing. In conclusion, we have developed a novel wound matrix-inducing membrane with slow linagliptin release that promotes chronic wound healing by modulating macrophage pyroptosis.

Schlagwörter

Stichwörter der Autor:innen

DPP-4 inhibitorchronic inflammationelectrospinningskin regeneration

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Department of Burns and Plastic Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

ORCID-Profile: Yizhuo Ren

Förderung

  • Shanghai Children’s Medical Center

Zitieren

APA

Ren, Y., Wang, Y., Cai, K., Lin, X., Tang, T., & Yin, M. (2026). PLGA/SF/linagliptin wound matrix-induced membrane promotes diabetic wounds healing by inhibiting macrophage pyroptosis. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag048

Vancouver

Ren Y, Wang Y, Cai K, Lin X, Tang T, Yin M. PLGA/SF/linagliptin wound matrix-induced membrane promotes diabetic wounds healing by inhibiting macrophage pyroptosis. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag048

BibTeX
@article{Ren2026,
  author = {Ren, Yizhuo and Wang, Yanlong and Cai, Kaixuan and Lin, Xianzheng and Tang, Tao and Yin, Meng},
  title = {PLGA/SF/linagliptin wound matrix-induced membrane promotes diabetic wounds healing by inhibiting macrophage pyroptosis},
  journal = {Regenerative Biomaterials},
  year = {2026},
  volume = {13},
  doi = {10.1093/rb/rbag048}
}
Kostenlos starten →